366 related articles for article (PubMed ID: 17236958)
1. Effect of bevacizumab on radiation necrosis of the brain.
Gonzalez J; Kumar AJ; Conrad CA; Levin VA
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab as a treatment option for radiation-induced cerebral necrosis.
Matuschek C; Bölke E; Nawatny J; Hoffmann TK; Peiper M; Orth K; Gerber PA; Rusnak E; Lammering G; Budach W
Strahlenther Onkol; 2011 Feb; 187(2):135-9. PubMed ID: 21336713
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab reverses cerebral radiation necrosis.
Wong ET; Huberman M; Lu XQ; Mahadevan A
J Clin Oncol; 2008 Dec; 26(34):5649-50. PubMed ID: 18981459
[No Abstract] [Full Text] [Related]
5. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
[TBL] [Abstract][Full Text] [Related]
6. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.
Torcuator R; Zuniga R; Mohan YS; Rock J; Doyle T; Anderson J; Gutierrez J; Ryu S; Jain R; Rosenblum M; Mikkelsen T
J Neurooncol; 2009 Aug; 94(1):63-8. PubMed ID: 19189055
[TBL] [Abstract][Full Text] [Related]
7. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
Gupta A; Muecke JS
Retina; 2008; 28(7):964-8. PubMed ID: 18698298
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of cerebral radiation necrosis by bevacizumab.
Jeyaretna DS; Curry WT; Batchelor TT; Stemmer-Rachamimov A; Plotkin SR
J Clin Oncol; 2011 Mar; 29(7):e159-62. PubMed ID: 21149667
[No Abstract] [Full Text] [Related]
9. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
Liu AK; Macy ME; Foreman NK
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1148-54. PubMed ID: 19857784
[TBL] [Abstract][Full Text] [Related]
10. Treatment of steroid refractory, Gamma Knife related radiation necrosis with bevacizumab: case report and review of the literature.
Sanborn MR; Danish SF; Rosenfeld MR; O'Rourke D; Lee JY
Clin Neurol Neurosurg; 2011 Nov; 113(9):798-802. PubMed ID: 21906869
[No Abstract] [Full Text] [Related]
11. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
[TBL] [Abstract][Full Text] [Related]
12. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
13. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
Mason JO; Albert MA; Persaud TO; Vail RS
Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
[TBL] [Abstract][Full Text] [Related]
15. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
[TBL] [Abstract][Full Text] [Related]
16. Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin).
Finger PT
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):974-7. PubMed ID: 18313522
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues.
Zhuang H; Shi S; Yuan Z; Chang JY
Mol Cancer; 2019 Feb; 18(1):21. PubMed ID: 30732625
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal brain imaging of five malignant glioma patients treated with bevacizumab using susceptibility-weighted magnetic resonance imaging at 7 T.
Grabner G; Nöbauer I; Elandt K; Kronnerwetter C; Woehrer A; Marosi C; Prayer D; Trattnig S; Preusser M
Magn Reson Imaging; 2012 Jan; 30(1):139-47. PubMed ID: 21982163
[TBL] [Abstract][Full Text] [Related]
19. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy.
Finger PT
Am J Ophthalmol; 2007 Feb; 143(2):335-8. PubMed ID: 17258524
[TBL] [Abstract][Full Text] [Related]
20. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
Furuse M; Kawabata S; Kuroiwa T; Miyatake S
J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
